The new NIDA U01 grant, “Characterization of Tandem Repeat and Structural Variants Contributing to Addictive Behaviors in Mice and Rats”, was awarded to MPI’s: Drs. Abraham Palmer, Melissa Gymrek and Jonatahn Sebat. This grant serves to combine the complementary expertise of the MPI’s to produce a large-scale resource for analyzing the effects of complex variation on mouse and rat phenotypes.
The article, “Multivariate genomic analysis of 1.5 million people identifies genes related to addiction, antisocial behavior, and health”, has been accepted for publication in Nature Neuroscience. Dr. Abraham Palmer and Dr. Sandra Sanchez-Roige are co-authors along with several others. The article can be found here. Abraham and Sandra are also members of the Externalizing Consortium.
The article, “The cocaine and oxycodone biobanks, two repositories from genetically diverse and behaviorally characterized rats for the study of addiction”, has been accepted for publication in eNeuro. Drs. Abraham Palmer and Oksana Polesskaya, and Apurva Chitre and Bonnie Lin are co-authors on the paper.
The article, “Item-level genome-wide association study of the Alcohol Use Disorders Identification Test in three population-based cohorts”, has been accepted for publication in The American Journal of Psychiatry. Drs. Abraham Palmer and Sandra Sanchez Roige are co-authors on the paper.
The article, “Genetic and pharmacological manipulations of glyoxalase 1 mediate ethanol withdrawal seizure susceptibility in mice”, has been accepted for publication in Brain Sciences. Drs. Abraham Palmer and Amanda Barkley-Levenson are co-authors on the paper.
The article, “Sensitivity to food and cocaine cues are independent traits in a large sample of heterogeneous stock rats”, has been accepted for publication in Scientific Reports. Apurva Chitre and Drs. Oksana Polesskaya and Abraham Palmer are co-authors on the paper.
Dr. Amelie Baud, a former Palmer lab postdoc, will start a Research Group Leader position at the Centre for Genomic Regulation in Barcelona, Spain in September 2021. Her lab will work on indirect genetic effects (genetic effects arising from heritable traits of social partners, when those traits influence the phenotype of interest) and host-microbiome interactions. She will keep collaborating with Dr. Palmer and the NIDA P50 Consortium. Congratulations, Amelie!